Ge Longhui, January 9 | Enhua Pharmaceutical (002262.SZ) announced that it recently received a written statement from Mr. Yin Xiaoxing, an independent director of the company. From January 1, 2024 until the expiration date of the sixth board of directors of the company, Mr. Yin Xiaoxing voluntarily relinquished the independent director allowances that he could receive in the company due to serving as an independent director of the company's sixth board of directors and related positions in the special committee of the board of directors. At the same time, he promised that the waiver of the above independent director allowance would not affect his normal performance as an independent director of the company. It will not affect his normal performance of duties as an independent director of the company's board of directors, nor will it affect its proper performance of duties in the special committee of the board of directors Responsibilities relating to the performance of duties.